The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D Molecular Therapeutics Inc | COM | 35104E100 | 5,691,543 | 271,155 | SH | SOLE | 271,155 | 0 | 0 | |||
Abbott Labs | COM | 002824100 | 40,545,682 | 390,200 | SH | Call | SOLE | 390,200 | 0 | 0 | ||
Achieve Life Sciences Inc | COM | 004468500 | 6,525,348 | 1,388,372 | SH | SOLE | 1,388,372 | 0 | 0 | |||
Align Technology Inc | COM | 016255101 | 52,758,249 | 218,524 | SH | SOLE | 218,524 | 0 | 0 | |||
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 35,946,747 | 147,929 | SH | SOLE | 147,929 | 0 | 0 | |||
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 12,150,000 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | ||
Amylyx Pharmaceuticals Inc | COM | 03237H101 | 570,000 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | ||
Amylyx Pharmaceuticals Inc | COM | 03237H101 | 569,413 | 299,691 | SH | SOLE | 299,691 | 0 | 0 | |||
AstraZeneca PLC | SPONSORED ADR | 046353108 | 62,502,512 | 801,417 | SH | SOLE | 801,417 | 0 | 0 | |||
Astria Therapeutics Inc | COM | 04635X102 | 552,297 | 60,692 | SH | SOLE | 60,692 | 0 | 0 | |||
Avantor Inc | COM | 05352A100 | 2,990,154 | 141,045 | SH | SOLE | 141,045 | 0 | 0 | |||
Avidity Biosciences Inc | COM | 05370A108 | 875,211 | 21,425 | SH | SOLE | 21,425 | 0 | 0 | |||
Axonics Inc | COM | 05465P101 | 10,117,443 | 150,490 | SH | SOLE | 150,490 | 0 | 0 | |||
Axsome Therapeutics Inc | COM | 05464T104 | 24,970,939 | 310,198 | SH | SOLE | 310,198 | 0 | 0 | |||
Baxter Intl Inc | COM | 071813109 | 3,939,373 | 117,769 | SH | SOLE | 117,769 | 0 | 0 | |||
Boston Scientific Corp | COM | 101137107 | 13,174,871 | 171,080 | SH | SOLE | 171,080 | 0 | 0 | |||
Cabaletta Bio Inc | COM | 12674W109 | 9,128,592 | 1,220,400 | SH | SOLE | 1,220,400 | 0 | 0 | |||
Celldex Therapeutics Inc | COM | 15117B202 | 20,270,636 | 547,707 | SH | SOLE | 547,707 | 0 | 0 | |||
Cogent Biosciences Inc | COM | 19240Q201 | 23,378,801 | 2,773,286 | SH | SOLE | 2,773,286 | 0 | 0 | |||
Dexcom Inc | COM | 252131107 | 6,972,190 | 61,494 | SH | SOLE | 61,494 | 0 | 0 | |||
Disc Medicine Inc | COM | 254604101 | 1,318,568 | 29,256 | SH | SOLE | 29,256 | 0 | 0 | |||
Dyne Therapeutics Inc | COM | 26818M108 | 57,371,059 | 1,625,703 | SH | SOLE | 1,625,703 | 0 | 0 | |||
Edgewise Therapeutics Inc | COM | 28036F105 | 8,567,195 | 475,691 | SH | SOLE | 475,691 | 0 | 0 | |||
Edwards Lifesciences Corp | COM | 28176E108 | 66,896,663 | 724,225 | SH | SOLE | 724,225 | 0 | 0 | |||
Edwards Lifesciences Corp | COM | 28176E108 | 46,185,000 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | ||
Elanco Animal Health Inc | COM | 28414H103 | 41,331,128 | 2,864,250 | SH | SOLE | 2,864,250 | 0 | 0 | |||
Erasca Inc | COM | 29479A108 | 4,010,886 | 1,699,528 | SH | SOLE | 1,699,528 | 0 | 0 | |||
Establishment Labs Hldgs Inc | COM | G31249108 | 19,504,847 | 429,244 | SH | SOLE | 429,244 | 0 | 0 | |||
Exact Sciences Corp | COM | 30063P105 | 7,682,233 | 181,828 | SH | SOLE | 181,828 | 0 | 0 | |||
IDEAYA Biosciences Inc | COM | 45166A102 | 40,430,148 | 1,151,528 | SH | SOLE | 1,151,528 | 0 | 0 | |||
IDEXX Labs Inc | COM | 45168D104 | 31,113,566 | 63,862 | SH | SOLE | 63,862 | 0 | 0 | |||
Immatics N.V | W EXP 07/01/2025 | N44445117 | 932,855 | 348,731 | SH | SOLE | 348,731 | 0 | 0 | |||
Immatics N.V | SHS | N44445109 | 9,257,700 | 796,704 | SH | SOLE | 796,704 | 0 | 0 | |||
Immunome Inc | COM | 45257U108 | 7,933,728 | 655,680 | SH | SOLE | 655,680 | 0 | 0 | |||
Inari Med Inc | COM | 45332Y109 | 7,503,600 | 155,838 | SH | SOLE | 155,838 | 0 | 0 | |||
Inhibrx Biosciences Inc | COM | 45720N103 | 6,565,174 | 463,315 | SH | SOLE | 463,315 | 0 | 0 | |||
Insmed Inc | COM PAR $.01 | 457669307 | 15,259,049 | 227,747 | SH | SOLE | 227,747 | 0 | 0 | |||
Inspire Med Sys Inc | COM | 457730109 | 1,338,300 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
Insulet Corp | COM | 45784P101 | 12,303,141 | 60,967 | SH | SOLE | 60,967 | 0 | 0 | |||
Intuitive Surgical Inc | COM | 46120E602 | 38,798,482 | 87,217 | SH | SOLE | 87,217 | 0 | 0 | |||
Intuitive Surgical Inc | COM | 46120E602 | 22,242,500 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | ||
Invesco QQQ TR | UNIT SER 1 | 46090E103 | 191,644,000 | 400,000 | SH | Put | SOLE | 400,000 | 0 | 0 | ||
Kura Oncology Inc | COM | 50127T109 | 16,991,753 | 825,243 | SH | SOLE | 825,243 | 0 | 0 | |||
Kyverna Therapeutics Inc | COM | 501976104 | 358,875 | 47,850 | SH | SOLE | 47,850 | 0 | 0 | |||
LivaNova PLC | SHS | G5509L101 | 1,129,402 | 20,602 | SH | SOLE | 20,602 | 0 | 0 | |||
Madrigal Pharmaceuticals Inc | COM | 558868105 | 12,443,867 | 44,417 | SH | SOLE | 44,417 | 0 | 0 | |||
Marinus Pharmaceuticals Inc | COM | 56854Q200 | 4,857,344 | 4,151,576 | SH | SOLE | 4,151,576 | 0 | 0 | |||
Marinus Pharmaceuticals Inc | COM | 56854Q200 | 122,499 | 104,700 | SH | Call | SOLE | 104,700 | 0 | 0 | ||
Masimo Corp | COM | 574795100 | 2,539,076 | 20,161 | SH | SOLE | 20,161 | 0 | 0 | |||
Novo-Nordisk A S | ADR | 670100205 | 92,715,482 | 649,541 | SH | SOLE | 649,541 | 0 | 0 | |||
PepGen Inc | COM | 713317105 | 8,955,603 | 561,128 | SH | SOLE | 561,128 | 0 | 0 | |||
Perspective Therapeutics Inc | COM | 46489V302 | 1,316,927 | 132,089 | SH | SOLE | 132,089 | 0 | 0 | |||
Pharvaris N V | COM | N69605108 | 11,308,839 | 601,534 | SH | SOLE | 601,534 | 0 | 0 | |||
Phibro Animal Health Corp | CL A COM | 71742Q106 | 3,974,641 | 237,009 | SH | SOLE | 237,009 | 0 | 0 | |||
Pulmonx Corp | COM | 745848101 | 381,960 | 60,246 | SH | SOLE | 60,246 | 0 | 0 | |||
Rapport Therapeutics Inc | COM | 75383L102 | 2,052,346 | 88,235 | SH | SOLE | 88,235 | 0 | 0 | |||
Revolution Medicines Inc | COM | 76155X100 | 17,662,392 | 455,099 | SH | SOLE | 455,099 | 0 | 0 | |||
Roivant Sciences Ltd | SHS | G76279101 | 19,749,115 | 1,868,412 | SH | SOLE | 1,868,412 | 0 | 0 | |||
Sarepta Therapeutics Inc | COM | 803607100 | 30,944,616 | 195,852 | SH | SOLE | 195,852 | 0 | 0 | |||
Savara Inc | COM | 805111101 | 21,596,440 | 5,358,918 | SH | SOLE | 5,358,918 | 0 | 0 | |||
Savara Inc | COM | 805111101 | 604,500 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | ||
Soleno Therapeutics Inc | COM | 834203309 | 22,617,847 | 554,359 | SH | SOLE | 554,359 | 0 | 0 | |||
Spdr Ser Tr | S&P BIOTECH | 78464A870 | 23,177,500 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | ||
Structure Therapeutics Inc | SPONSORED ADS | 86366E106 | 350,092 | 8,915 | SH | SOLE | 8,915 | 0 | 0 | |||
Stryker Corporation | COM | 863667101 | 65,696,831 | 193,084 | SH | SOLE | 193,084 | 0 | 0 | |||
Syndax Pharmaceuticals Inc | COM | 87164F105 | 44,214,825 | 2,153,669 | SH | SOLE | 2,153,669 | 0 | 0 | |||
TG Therapeutics Inc | COM | 88322Q108 | 33,112,118 | 1,861,277 | SH | SOLE | 1,861,277 | 0 | 0 | |||
Teleflex Incorporated | COM | 879369106 | 2,870,794 | 13,649 | SH | SOLE | 13,649 | 0 | 0 | |||
Waters Corp | COM | 941848103 | 6,325,776 | 21,804 | SH | SOLE | 21,804 | 0 | 0 | |||
Zimmer Biomet Holdings Inc | COM | 98956P102 | 1,153,674 | 10,630 | SH | SOLE | 10,630 | 0 | 0 | |||
Aerovate Therapeutics Inc | COM | 008064107 | 6,239,419 | 3,758,686 | SH | SOLE | 3,758,686 | 0 | 0 | |||
Arrivent BioPharma Inc | COM | 04272N102 | 31,474,750 | 1,696,752 | SH | SOLE | 1,696,752 | 0 | 0 | |||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 100,141,652 | 734,284 | SH | SOLE | 734,284 | 0 | 0 | |||
Bolt Biotherapeutics Inc | COM | 097702104 | 2,065,828 | 2,754,437 | SH | SOLE | 2,754,437 | 0 | 0 | |||
Ikena Oncology Inc | COM | 45175G108 | 631,316 | 382,616 | SH | SOLE | 382,616 | 0 | 0 | |||
Inozyme Pharma Inc | COM | 45790W108 | 19,090,174 | 4,280,308 | SH | SOLE | 4,280,308 | 0 | 0 | |||
Natera Inc | COM | 632307104 | 167,879,821 | 1,550,280 | SH | SOLE | 1,550,280 | 0 | 0 | |||
Nextcure Inc | COM | 65343E108 | 4,248,251 | 2,671,856 | SH | SOLE | 2,671,856 | 0 | 0 | |||
PDS Biotechnology Corp | COM | 70465T107 | 417,921 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | |||
Rapport Therapeutics Inc | COM | 75383L102 | 43,340,986 | 1,863,327 | SH | SOLE | 1,863,327 | 0 | 0 | |||
Vera Therapeutics Inc | CL A | 92337R101 | 101,086,450 | 2,793,987 | SH | SOLE | 2,793,987 | 0 | 0 | |||
Y-mAbs Therapeutics Inc | COM | 984241109 | 26,506,878 | 2,194,278 | SH | SOLE | 2,194,278 | 0 | 0 |